BIOSAFETY WEBCAST
About
This webcast will describe strategies and best practices for developing and implementing virus testing programs and explain test methods for virus detection and quantitation during various biopharmaceutical manufacturing phases.
Starts
May 20, 2014, 11:00
Ends
May 27, 2014, 11:00
Effective Viral Contamination Testing Programs for Biologics Product Manufacturing
This webcast is brought to you by SGS, in collaboration with BioPharm International. During this event experts will describe strategies and best practices for developing and implementing effective virus testing programs, including a review of regulatory guidance. In addition, you will learn about test methods for virus detection and quantitation during various biopharmaceutical manufacturing phases. A range of testing technologies, including in vitro adventitious virus assays, PCR, ELISA, plaque assays, and electron microscopy, as well as sampling methods, will be discussed.
Key Learning Objectives:
·
Develop a comprehensive plan for effective testing for viral contaminants
·
Review current testing methods and revise current methods to ensure product safety
·
Understand pros and cons for various methods for detecting viruses
Moderator:
Archie Lovatt
The webinar will be presented on:
IMPORTANT - PLEASE READ
Rita Peters
Editorial Director
Pharmaceutical Technology
Speakers:
Ruth Paul
Director
Paul Regulatory Consulting Services
Scientific Operations Director
SGS Vitrology
Euan W. Milne
Electron Microscopist
SGS Life Science Services
US
Tuesday, May 20 at 11:00 am EDT
EU Tuesday, May 27 at 11:00 am CET
This is a FREE streaming audio Webcast and does not require a phone line. If you have any questions regarding this Webcast, please contact Sara Barschdorf,
sbarschdorf@advanstar.com
.